BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 17638589)

  • 1. Restless legs syndrome (RLS) with expansion of symptoms to the face.
    Buchfuhrer MJ
    Sleep Med; 2008 Jan; 9(2):188-90. PubMed ID: 17638589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute.
    García-Borreguero D; Allen RP; Kohnen R; Högl B; Trenkwalder C; Oertel W; Hening WA; Paulus W; Rye D; Walters A; Winkelmann J; Earley CJ;
    Sleep Med; 2007 Aug; 8(5):520-30. PubMed ID: 17544323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of recalcitrant restless legs syndrome with botulinum toxin type-A.
    Rotenberg JS; Canard K; Difazio M
    J Clin Sleep Med; 2006 Jul; 2(3):275-8. PubMed ID: 17561538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of an algorithm for the diagnosis of Restless Legs Syndrome: The Restless Legs Syndrome-Diagnostic Index (RLS-DI).
    Benes H; Kohnen R
    Sleep Med; 2009 May; 10(5):515-23. PubMed ID: 18823819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of botulinum toxin A to relieve restless legs syndrome.
    Ghorayeb I; Burbaud P
    Sleep Med; 2009 Mar; 10(3):394-5. PubMed ID: 18514023
    [No Abstract]   [Full Text] [Related]  

  • 6. Restless legs syndrome in 2004.
    Sonka K; Kemlink D
    Prague Med Rep; 2004; 105(4):337-56. PubMed ID: 15822631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin A: new hope for RLS?
    Kushida CA
    J Clin Sleep Med; 2006 Jul; 2(3):279-80. PubMed ID: 17561539
    [No Abstract]   [Full Text] [Related]  

  • 8. Methadone for refractory restless legs syndrome.
    Ondo WG
    Mov Disord; 2005 Mar; 20(3):345-8. PubMed ID: 15580610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The severity range of restless legs syndrome (RLS) and augmentation in a prospective patient cohort: association with ferritin levels.
    Frauscher B; Gschliesser V; Brandauer E; El-Demerdash E; Kaneider M; Rücker L; Poewe W; Högl B
    Sleep Med; 2009 Jun; 10(6):611-5. PubMed ID: 19200780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Restless legs syndrome in patients on dialysis for kidney insufficiency: effect of medication].
    Hohl-Radke F; Aedtner F; Domröse U; Neumann KH; Staedt J
    Dtsch Med Wochenschr; 2008 Jan; 133(3):71-5. PubMed ID: 18186007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type A: history and current cosmetic use in the upper face.
    Carruthers A; Carruthers J
    Semin Cutan Med Surg; 2001 Jun; 20(2):71-84. PubMed ID: 11474747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empirical evaluation of the accuracy of diagnostic criteria for Restless Legs Syndrome.
    Benes H; von Eye A; Kohnen R
    Sleep Med; 2009 May; 10(5):524-30. PubMed ID: 18996741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can the sensory symptoms of restless legs syndrome be assessed using a qualitative pain questionnaire?
    Bentley AJ; Rosman KD; Mitchell D
    Clin J Pain; 2007 Jan; 23(1):62-6. PubMed ID: 17277646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and symptom rating scale of restless legs syndrome].
    Inoue Y
    Brain Nerve; 2009 May; 61(5):533-8. PubMed ID: 19514513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Six months treatment of restless legs syndrome with levodopa/benserazide in domiciliary practice].
    Mühlau G
    MMW Fortschr Med; 2004 Dec; 146(Suppl 3-4):87-93. PubMed ID: 15662897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot trial of onabotulinumtoxina (Botox) in moderate to severe restless legs syndrome.
    Agarwal P; Sia C; Vaish N; Roy-Faderman I
    Int J Neurosci; 2011 Nov; 121(11):622-5. PubMed ID: 21740308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of restless legs syndrome: the current status.
    Garcia-Borreguero D; Egatz R; Winkelmann J; Berger K
    Sleep Med Rev; 2006 Jun; 10(3):153-67. PubMed ID: 16762806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restless legs syndrome in an Indian urban population.
    Rangarajan S; Rangarajan S; D'Souza GA
    Sleep Med; 2007 Dec; 9(1):88-93. PubMed ID: 17825618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of ropinirole for restless legs syndrome is not affected by age at symptom onset.
    Allen RP; Ritchie SY
    Sleep Med; 2008 Dec; 9(8):899-902. PubMed ID: 18024167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Restless legs, restless nights: therapeutic options in RLS].
    Kassubek J; Unrath A
    MMW Fortschr Med; 2009 Mar; 151(13):65-7, 69. PubMed ID: 19504823
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.